ARCHIVES

AACR Says 5 Percent Of Meeting Registrants Couldn’t Attend Due To Volcanic Ash In Europe

This article is from The Cancer Letter archive.

Vol. 36 No. 16 | April 30, 2010

Download PDF Visit The Full Archive

Related Articles

Drug Development: ODAC Discussion May Offer Clues For Sponsors of Cytostatic Drugs

June 16, 1999

Most of NCI’s Increase For Breast Cancer to Fund Grants: Broder

May 21, 1993

NCAB Gives Okay To Comp Center Guidelines

December 7, 1979

NCI Needs 100 SBIR Contracts By April 1 To Avoid Losing $5 Million; NIH Objects To DCT Comments

March 22, 1985

Turmoil in Texas: DePinho Recommended AVEO Stock on CNBC Six Days After FDA Said New Trial Was Needed

May 10, 2013

Cancer Groups Endorse Pazdur For FDA Commissioner.

January 19, 2001